This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

顯示第 1 至 16 項結果，共 39 項

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXB)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXF)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXL)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXM)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXS)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0-VXX)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.0)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.3-BT)

• 

  查看內容

  Anti-CD134 [OX86] (Ab00110-2.3)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4-VXB)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4-VXF)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4-VXL)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4-VXM)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4-VXX)

• 

  查看內容

  Anti-CD200R [OX131] (Ab00111-1.4)

• 

  查看內容

  Anti-CD28 [JJ316] (Ab00284-8.1-BT)